chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.79
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 16Oct02, concerning a 22 month old male vaccinee who was inadvertently administered 0.25ml IM into the vastus lateralis on the 15Oct02. On 15Oct02, the vaccinee suffered a medication error by receiving 0.25ml Fluvirin into the vastus lateralis. The vaccinee had not experienced any adverse events at the time of the report but was being closely monitored. There was insufficient information to determine the reporter's causality assessment. PJP200200609, PJP200200671, PJP200200670, PJP200200669, PJP200200668, PJP200200667, PJP200200666, PJP200200665, PJP200200664, PJP200200662.
Age: 0.87
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 16Oct02, concerning a 22 month old male vaccinee who was inadvertently administered 0.25ml IM into the vastus lateralis on the 15Oct02. On 15Oct02, the vaccinee suffered a medication error by receiving 0.25ml Fluvirin into the vastus lateralis. The vaccinee had not experienced any adverse events at the time of the report but was being closely monitored. There was insufficient information to determine the reporter's causality assessment. PJP200200609, PJP200200671, PJP200200670, PJP200200669, PJP200200668, PJP200200667, PJP200200666, PJP200200665, PJP200200662, PJP200200663.
Age: 1.29
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 16Oct02, concerning a 22 month old male vaccinee who was inadvertently administered 0.25ml IM into the vastus lateralis on the 15Oct02. On 15Oct02, the vaccinee suffered a medication error by receiving 0.25ml Fluvirin into the vastus lateralis. The vaccinee had not experienced any adverse events at the time of the report but was being closely monitored. There was insufficient information to determine the reporter's causality assessment. PJP200200609, PJP200200671, PJP200200670, PJP200200669, PJP200200668, PJP200200667, PJP200200666, PJP200200664, PJP200200662, PJP200200663.
Age: 0.54
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 16Oct02, concerning a 6 month old male vaccinee who was inadvertently administered 0.25ml IM into the vastus lateralis on the 16Oct02. On 16Oct02, the infant suffered a medication error by receiving 0.25ml Fluvirin into the vastus lateralis. The infant had not experienced any adverse events at the time of the report but was being closely monitored. There was insufficient information to determine the reporter's causality assessment. PJP200200609, PJP200200671, PJP200200670, PJP200200669, PJP200200668, PJP200200667, PJP200200665, PJP200200664, PJP200200662, PJP200200663.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 16Oct02, concerning a 6 month old male vaccinee who was inadvertently administered 0.25ml IM into the vastus lateralis on the 16Oct02. On 16Oct02, the infant suffered a medication error by receiving 0.25ml Fluvirin into the vastus lateralis. The infant had not experienced any adverse events at the time of the report but was being closely monitored. There was insufficient information to determine the reporter's causality assessment. PJP200200609, PJP200200671, PJP200200670, PJP200200669, PJP200200668, PJP200200666, PJP200200665, PJP200200664, PJP200200662, PJP200200663.
Age: 1.71
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 16Oct02, concerning a 6 month old male vaccinee who was inadvertently administered 0.25ml IM into the vastus lateralis on the 16Oct02. On 16Oct02, the infant suffered a medication error by receiving 0.25ml Fluvirin into the vastus lateralis. The infant had not experienced any adverse events at the time of the report but was being closely monitored. There was insufficient information to determine the reporter's causality assessment. PJP200200609, PJP200200671, PJP200200670, PJP200200669, PJP200200667, PJP200200666, PJP200200665, PJP200200664, PJP200200662, PJP200200663.
Age: 1.22
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 16Oct02, concerning a 6 month old male vaccinee who was inadvertently administered 0.25ml IM into the vastus lateralis on the 16Oct02. On 16Oct02, the infant suffered a medication error by receiving 0.25ml Fluvirin into the vastus lateralis. The infant had not experienced any adverse events at the time of the report but was being closely monitored. There was insufficient information to determine the reporter's causality assessment. PJP200200609, PJP200200671, PJP200200670, PJP200200668, PJP200200667, PJP200200666, PJP200200665, PJP200200664, PJP200200662, PJP200200663.
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 16Oct02, concerning a 7 month old female vaccinee who was inadvertently administered 0.25ml Fluvirin IM into vastus lateralis on the 15Oct02. On 15Oct02, the infant suffered a medication error by receiving 0.25ml Fluvirin into vastus lateralis. The infant had not experienced any adverse events at the time of the report but was being closely monitored. There was insufficient information to determine the reporter's causality assessment.  PJP200200609, PJP200200671, PJP200200669, PJP200200668, PJP200200667, PJP200200666, PJP200200665, PJP200200664, PJP200200662, PJP200200663.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 16Oct02, concerning a 3 year old male vaccinee who was inadvertently administered 0.5ml Fluvirin IM into vastus lateralis on the 14Oct02. On 14Oct02, the vaccinee suffered a medication error by receiving 0.5ml Fluvirin into the vastus lateralis. The infant had not experienced any adverse events at the time of the report but was being closely monitored. There was insufficient information to determine the reporter's causality assessment. PJP200200609, PJP200200670, PJP200200669, PJP200200668, PJP200200667, PJP200200666, PJP200200665, PJP200200664, PJP200200662, PJP200200663.
Age: 87.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Injection site erythema, Injection site pain, Pyrexia, Rash
Clinical narrative: A report was received from a health care professional on 11/01/02, concerning a female vaccinee older than 60 years who experienced chills 4 hours after receiving 0.5 ml Fluvirin intramuscularly, soreness and erythema at the injection site on the following day. On 10/25/02, the vaccinee experienced chills beginning approximately 4 hours following vaccination. The following morning the vaccinee experienced soreness and erythema (5'x3") around the injection site which lasted 5 days. The vaccinee had recovered at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update (1) 12/18/02: A report was received indicating that the vaccinee was 87 years old. Vaccination occurred on 10/24/02. The vaccinee experienced a red rash and fever which began on 10/24/02 and lasted 2 weeks. The red rash and fever resolved. There was insufficient information to determine the reporter's causality assessment. Ref: PJP200200673 and PJP200200674.
Age: 62.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain, Pyrexia
Clinical narrative: A report was received from a health care professional on 11/1/02, concerning a male vaccinee older than 60 years who experienced soreness and erythema at the injection site one day after receiving 0.5ml of Fluvirin intramuscularly on 10/25/02. On 26/02, the vaccinee experienced soreness and erythema (5"x4") at the injection site the morning after receiving Fluvirin on 10/25/02. the vaccinee has recovered at the time of the report. The vaccinee received Fluvirin last year without any adverse symptoms. There was insufficient information to determine the reporter's causality assessment. Update (1) 12/18/02: A report was received indicating that the vaccinee was a 62 year old female. The vaccinee also experienced chills and fever which began on 10/19/02 and lasted 1 week. The chills and fever have resolved. There was insufficient information to determine the reporter's causality assessment. Cross reference with: PJP200200672 and PJP200200674.
Age: 71.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Injection site erythema, Injection site pain, Injection site warmth, Pyrexia
Clinical narrative: A report was received from a health care professional on 11/01/02, concerning a male vaccinee older than 60 years who experienced chills, soreness and erythema of the arm one day after receiving 0.5ml Fluvirin intramuscularly on 10/30/02. On 10/30/02, the vaccinee experienced chills approximately 4 hour post vaccination. The following morning, the vaccinee experienced soreness and erythema from the injection site to the elbow and encircling the arm. The vaccinee had not recovered at the time of reporting and is currently taking prophylactic antibiotics. the vaccinee received Fluvirin last year without any adverse symptoms. There was insufficient information to determine the reporter's causality assessment. Update (1) 12/18/02: A 71 year old vaccinee experienced fever and a red area was hot to touch after receiving Fluvirin on 10/30/02. It was reported that symptoms lasted a week and then resolved.
Age: 56.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: A report received from a consumer on 11/04/02, concerning a 55 year old female vaccinee who experienced pain, redness, swelling and warmth at the injection site a few hours after receiving the Fluvirin vaccine in the upper arm on 10/29/02. On 10/29/02, the vaccinee experienced severe pain, redness, swelling and warmth at the injection site which worsened for a few days. On 11/1/02, the vaccinee was seen by a dermatologist for a routine examination and was advised to place ice packs on the affected area. The vaccinee did not take any medication to relieve the symptoms. At the time of this report the symptoms are alleviated and tolerable but not completely resolved. The vaccinee has previously received influenza injections (brand unspecified) for many years without any problems.
Sex: F
Vaccine: FLU3
Symptoms: Paraesthesia, Paraesthesia oral
Clinical narrative: A report was received from a health care professional on 11/04/02, concerning a female vaccinee in her 30's who experienced a tingling sensation on her lips and cheeks 30-45 minutes after receiving Fluvirin intramuscularly on 11/04/02. The symptoms had not resolved at the time of the report. It was reported that the vaccinee had not been exposed to influenza vaccine before nor had any allergy to eggs. The reporter has assessed the relationship of the vaccine to the event as probable.
Age: 46.0
Sex: F
Vaccine: FLU3, FLUX
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 21Oct02, concerning a female vaccinee who was inadvertently administered last years batch of Fluvirin on 18Oct02. On 18Oct02, the vaccinee received 0.5ml Fluvirin IM. It was discovered later that it was last years batch. No adverse effects were reported at time of reporting. There was insufficient information to determine the reporter's causality assessment.  Ref: PJP200200677. Update 1 12Feb03: A report was received from a health care professional concerning a 46 year old vaccinee. The vaccinee was revaccinated with the 2003 vaccine (brand unspecified) on an unspecified date. The vaccinee experienced no adverse event at the time of the report.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Feeling hot, Injection site erythema, Medication error
Clinical narrative: A report was received from a health care professional on 01Nov02 concerning a 50 year old female vaccinee who was inadvertently administered Fluvirin SC and experienced local redness and warmth at the injection site one day after receiving Fluvirin on 24Oct02. On 24Oct02 the vaccinee was inadvertently admin 0.5ml Fluvirin SC. On 25Oct02 the vaccinee experienced local redness and warmth at the injection site. The vaccinee had recovered at the time of the report. The reporter has assessed the relationship of the vaccinee to the event as probable.
Age: 59.0
Sex: M
Vaccine: FLU3
Symptoms: Arthralgia, Injection site erythema, Injection site pain
Clinical narrative: A report received from a health care professional on 01Nov02, concerning a 59 year old male vaccinee who experienced soreness, redness at the injection site and arthralgia 1 day after receiving Fluvirin on 30Oct02. On 31Oct02, the vaccinee experienced soreness, redness and arthralgia at the injection site after receiving Fluvirin. The vaccinee also received a pneumonia vaccine on 30Oct02 on the opposite arm, and also experienced soreness, redness, and arthralgia of a greater degree of severity at that injection site on 31Oct02. The vaccinee was prescribed diphenhydramine hydrochloride 25mg orally every 6 hours (with 50mg at bedtime for 3 days). If the reaction continues the physician will be prescribing Levofloxacin. At the time of reporting the vaccinee has not yet recovered. The reporter has assessed the relationship of the vaccine to the event probable and indicated that the event was a local allergic reaction to the vaccination.
Age: 24.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: A report received from a health professional on 01Nov02 concerning a 23 year old female vaccinee who experienced soreness and erythema at the injection site on the same day she received Fluvirin on 30Oct02. On 30Oct02, the pt experienced soreness and erythema, 1.5 inches in diameter, at the injection site. The pt has had no prior influenza vaccination and has no history of egg allergy. At the time of reporting the pt had not yet recovered. The reporter has assessed the relationship of the vaccine to the event as probable.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site reaction, Tenderness
Clinical narrative: A report received from a healthcare professional on 05Nov02 concerning a 55 year old female vaccinee who experienced an injection site reaction two days after receiving Fluvirin on 29Oct02. On 31Oct02 the vaccinee complained of redness and tenderness of an 19x 10cm area at the injection site. The pt received methylprednisolone to treat the symptoms of the event. The outcome of this event is unk. There was insufficient information to determine the reporter's causality assessment.  See Ref: PJP200200683, PJP200200684, PJP200200685, PJP200200686.
Sex: M
Vaccine: FLU3
Symptoms: Headache, Injection site erythema, Pruritus, Skin burning sensation
Clinical narrative: A report received from a healthcare professional on 05Nov02 concerning a male vaccinee in his forties who experienced headache and redness, itching and burning immediately after receiving Fluvirin on 01Nov02.  On 01Nov02 the vaccinee complained of headache and of redness, itching and burning that extended from the upper arm to the elbow. No medical intervention was required as the symptoms were self-limiting. The symptoms resolved within 1 day and the pt has recovered from the event. There was insufficient information to determine the reporter's causality assessment. See Ref: PJP200200682, PJP200200684, PJP200200685, PJP200200686.
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Pruritus, Skin burning sensation
Clinical narrative: A report received from a health professional on 05Nov02 concerning a female vaccinee in her fifties who experienced an injection site reaction the morning after receiving Fluvirin on 01Nov02. On the morning of 02Nov02 the vaccinee complained of redness, itching and burning at the injection site. No medical intervention was required as the symptoms were self limiting. The symptoms resolved within a day and the pt is currently recovered. There was insufficient information to determine the reporters causality assessment. See Ref: PJP200200682, PJP200200683, PJP200200685, PJP200200686
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Pruritus, Skin burning sensation
Clinical narrative: A report received from a healthcare professional on 05Nov02, concerning a female vaccinee in her fifties who experienced an injection site reaction the morning after receiving Fluvirin on 01Nov02. On the morning of 02Nov02 the vaccinee complained of redness, itching, and burning at the injection site. No medical intervention was required since the symptoms were self limiting. The symptoms resolved within one day and the pt has recovered. There was insufficient information to determine the reporter's causality assessment. See Ref: PJP200200682, PJP200200683, PJP200200684, PJP200200686.
Sex: U
Vaccine: FLU3
Symptoms: Injection site erythema, Pruritus, Skin burning sensation
Clinical narrative: A report received from a healthcare professional on 05Nov02, concerning a vaccinee (age and gender unk) who experienced an injection site reaction the morning after receiving Fluvirin on 01Nov02. On the morning of 02Nov02 the vaccinee complained of redness, itching, and burning at the injection site. No medical intervention was required since the symptoms were self limiting. The symptoms resolved within one day and the pt has recovered. There was insufficient information to determine the reporter's causality assessment. See Ref: PJP200200682, PJP200200683, PJP200200684, PJP200200685.
Sex: U
Vaccine: FLU3
Symptoms: Chills
Clinical narrative: A report was received from a health care professional on 04Nov02 concerning a group of three vaccinees who experienced chills 5 days after receiving Fluvirin on 29Oct02. On 03Nov02 the vaccinees experienced chills 5 days after receiving 0.5ml Fluvirin IM. Vaccinees were residents of a long term care facility. The attending nurse felt that the chills should be investigated as possibly related to the vaccine although the attending physician was doubtful about this.
Sex: U
Vaccine: FLUX
Symptoms: Medication error
Clinical narrative: A report received from a health professional on 04Nov02, concerning a vaccinee of unk demography who was administered expired influenza vaccine (brand unspecified) on 04Nov02. On 04Nov02, the vaccinee was inadvertently administered expired influenza vaccine (brand unspecified). No adverse event was reported. The vaccinee will be closely monitored for adverse events. There was insufficient information to determine the reporter's causality assessment.
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received from a health professional on 08Nov02, concerning a female vaccinee  who inadvertently received Fluvirin SC on 07Nov02. On 07Nov02 the vaccinee received 0.5ml Fluvirin SC.  No adverse event was reported in relation to the incident. There was insufficient information to determine the reporter's causality assessment.  Cross reference with: PJP200200731, PJP200200729, PJP200200743, PJP200200728, PJP200200742, PJP200200741, PJP200200720, PJP200200745.
Sex: F
Vaccine: FLU3
Symptoms: Dyspnoea
Clinical narrative: A report was received from a health care professional concerning a female vaccinee in her 40s who experienced a shortness of breath hours after receiving 0.5ml Fluvirin on 28Oct02. On 28Oct02 the vaccinee experienced shortness of breath more than 20 minutes after vaccination with 0.5ml Fluvirin IM. The vaccinee was seen in an urgent care clinic and then transferred to the ER of an unspecified hospital. Details of the ER visit were not reported. On 29Oct the vaccinee was reported to be fine and her condition resolved without sequelae. The reporter has assessed the relationship of the vaccine to the event as unclassifiable.
Age: 2.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health professional on 17Oct02, concerning a 2 year old male vaccinee who was inadvertently administered 0.5ml Fluvirin on 15Oct02. On 15Oct02, the vaccinee experienced an overdose after inadvertently receiving 0.5ml Fluvirin. No adverse effects were reported at time of report. No other information was available. There was insufficient information to determine the reporter's causality assessment.
Age: 72.0
Sex: M
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 31Oct02 concerning a male vaccinee of unk demography who received 0.5ml Fluvirin SC on 31October02. There was insufficient information to determine the reporter's causality assessment. Update 1, 03Dec02: A report was from a health care professional indicating that the vaccinee was 72 years old. No adverse reaction was reported.
Age: 79.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional concerning a 78 year old male vaccinee who was inadvertently administered last years batch of Fluvirin on 23Oct02. On 23Oct02 the vaccinee was administered 0.5ml Fluvirin IM which was found to be last years batch of Fluvirin with expiration date 30Jun02. No adverse reaction was reported in relation to the vaccination. The reporter has assessed the relationship of the vaccine to the event as unclassifiable.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received from a health care professional on 04Nov02 concerning an unk number of vaccinees who inadvertently received frozen Fluvirin on an unk date. On an unk date, an unk number of vaccinees were inadvertently administered frozen Fluvirin. The reporter was not aware of any adverse reactions experienced by the vaccinees. There was insufficient information to determine the reporter's causality assessment.
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received from a health care professional on 06Nov02 concerning a female vaccinee of less than 4 years old who was inadvertently administered 0.25ml Fluvirin on 25Oct02. On 25Oct02 the vaccinee who was less than 4 years old was administered 0.25 ml Fluvirin IM. No adverse event was reported in relation to the incident.  There was insufficient information to determine the reporter's causality assessment. Cross reference with PJP200200706.
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received from a health care professional on 06Nov02 concerning a male vaccinee of less than 4 years old who was inadvertently administered 0.25ml Fluvirin on 25Oct02. On 25Oct02 the vaccinee who was less than 4 years old was administered 0.25 ml Fluvirin IM. No adverse event was reported in relation to the incident.  There was insufficient information to determine the reporter's causality assessment. Cross reference with PJP200200705.
Sex: U
Vaccine: FLU3
Symptoms: Dizziness, Headache
Clinical narrative: A report received from a health care professional on 06Nov02 concerning 2 adult vaccinees of unk demography who experienced headache and dizziness within 1 hour of receiving Fluvirin on 30Oct02. On 30Oct02 4 vaccinees experienced headache and dizziness within 1 hour of receiving Fluvirin. The vaccinees recovered the same day.  There was insufficient information to determine the reporter's causality assessment. Cross reference with PJP200200708 and PJP200200709.
Age: 61.0
Sex: F
Vaccine: FLU3
Symptoms: Arthritis, Chest pain, Dizziness, Headache
Clinical narrative: A report received from a health professional on 11/06/2002, concerning a 61 year old female vaccinee who experienced headache and diziness within 1 hour of receiving Fluvirin, and chest pain 3 days after receiving Fluvirin on 10/30/2002. On 10/30/2002, the vaccinee experienced headache and dizziness within 1 hour of receiving Fluvirin.  On 11/02/2002, the vaccinee experienced chest pain and was admitted to the emergency room for observation for 12 hours.  The ER physician indicated that the chest pain was associated with arthritic symptoms secondary to Fluvirin.  The vaccinee was treated with an anti-inflammatory agent and discharged home.  The symptoms resolved. There was insufficient information to determine the reporter's causality assessment. Cross reference with PJP-2002-7007 and PJP-2002-00708.
Sex: F
Vaccine: FLUX
Symptoms: Arthralgia
Clinical narrative: A report was received from a health care professional on 11/05/2002, concerning a female vaccinee in her 40s who experienced joint pain 1 week after receiving virus influenza on an unreported date in 2001. On an unreported date in 2001 the vaccinee experienced joint pain 1 week after receiving virus influenza. No treatment was administered and the joint pain resolved after a few days. The reporter has assessed the relationship of the vaccine to the event as unclassifiable.
Age: 3.17
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received from a health professional on 11/05/2002, concerning a 38 month old vaccinee who was inadvertently administered Fluvirin. On 10/29/2002, the vaccinee was inadvertently administered Fluvirin. No adverse event occurred. There was insufficient information to determine the reporter's causality assessment
Age: 69.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Night sweats, Urticaria
Clinical narrative: A report was received from a consumer on 11/04/2002, concerning a 69 year old female vaccinee who experienced hives and loss of energy (two days post-vaccination) and night sweats ( 7 days post-vaccination ) after receiving Fluvirin on 10/15/2002. On 10/17/2002 the vaccinee developed eight to ten hives on her legs and buttocks and complained of having no energy. Approximately a week after receiving the vaccine the vaccinee began to experience night sweats. The vaccinee's glucose sugar level was within normal limits when she experienced the night sweats. At the time of this report the patient was still experiencing night sweats. The hives and loss of energy were reported as resolved on an unknown date.
Sex: F
Vaccine: FLU3
Symptoms: Accidental overdose, Medication error
Clinical narrative: A report received from a health professional on 11/05/2002, concerning a female vaccinee of unknown age who received 2 administrations of Fluvirin. The vaccinee was administered 2 doses on 10/23/2002 and 11/04/2002. Both doses were administered intramuscularly in the deltoid region of the arm. No adverse events were observed. The reporter has assessed the relationship of the vaccine to the event as unclassifiable.
Age: 59.0
Sex: M
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: A report received from a health professional on 11/06/2002, concerning a 59 year old male vacinee who developed hives 3 days after receiving Fluvirin on 10/29/2002. On 11/01/2002 the vaccinee developed hives 3 days after receiving Fluvirin, the vaccinee did not have any other symptoms of an allergic reaction. The vaccinee treated himself with Benadryl. On 11/03/2002 the vaccinee recovered. There was insufficient information to determine the reporter's causality assessment.
Age: 2.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received from a health care professional on 11/06/02, concerning a 2 year old male vaccinee who was administered Fluvirin. On 11/04/02, the vaccinee was administered 0.25 ml of Fluvirin vaccine. No adverse symptoms were reported. There was insufficient information to determine the reporter's causality assessment. Update (1) 12/31/02: An update report was received from a health care professional which indicated that the vaccinee did not experienced any adverse effects at the time of the report.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Facial palsy, Fatigue, Headache
Clinical narrative: A report was received from a consumer on 11/05/02, concerning a 16 year old female who experienced right side facial paralysis, headache and fatigue after receiving Fluvirin on 10/24/02. On 10/24/02 the patient received a Fluvirin vaccine and experienced headache and fatigue on 10/25/02. On 10/28/02, the patient experienced facial paralysis. The patient could not mover any of her facial muscles from the top of her forehead to the collar bone on the right side of her face. The patient has been given methylprednisone for 6 days and valacyclovir 500 mg Q12H for 10 days for treatment of the adverse event. The headache and the fatigue recovered on 10/26 and 10/27 respectively, but the patient is still exhibiting symptoms of the paralysis. The patient was scheduled for a MRI for further evaluation. The reporter has assessed the relationship of study medication to the facial paralysis as possible. On 11/06/2, the patient contacted the manufacture again and requested compensation for the medical expenses incurred as a result of the adverse event. A follow up report was received from a health care professional on 12/02/02. The reporter diagnosed the vaccinee with partial facial paralysis. The vaccinee was described as "healthy" and event was improving. Results of the MRI examination was negative. There was insufficient information to determine the reporter's causality assessment.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received from a health care professional on 11/06/02, concerning approximately 100 vaccinees less than 4 years of age who were inadvertently administered Fluvirin on unknown dates. The reporter is in the process of indentifying the vaccinees. It is not known if any of the vaccinee's subsequently experienced adverse events. There was insufficient information to determine the reporter's causality assessment.
Age: 2.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/07/02, concerning a 2 year old female vaccinee who inadvertently received 0.5ml of Fluvirin on 11/06/02. There was insufficient information to determine the reporter's causality assesment.
Age: 81.0
Sex: F
Vaccine: FLU3
Symptoms: Diplopia, Vision blurred
Clinical narrative: A report was received from a health care professional on 11/08/02, concerning an 81 year old female vaccinee who experienced blurred vision and double vision immediately after receiving Fluvirin on 10/30/02. At the time of reporting the vaccinee had not yet recovered. There was insufficient information to determine the reporter's causality assessment.
Age: 83.0
Sex: M
Vaccine: FLU3
Symptoms: Diplopia
Clinical narrative: A report received from a healthcare professional on 11/08/02, concerning a 83 year old male vaccinee who experienced double vision one week after receiving Fluvirin on 10/30/2002. The vaccinee had not yet recovered at the time of reporting. There was insufficient information to determine the reporter's assessment of causality.
Age: 85.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received from a health care professional on 11/11/02, concerning an 85 year old male vaccinee who inadvertently received expired Fluvirin vaccine on an unknown date. No adverse events were experienced by the vaccinee. There was insufficient information to determine the reporter's causality assessment. See ref: PJP200200727
Age: 80.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received from a health care professional on 11/11/02, concerning an 80 year old female vaccinee who inadvertently received expired Fluvirin vaccine on an unknown date. The vaccinee did not experience any adverse events. There was insufficient information to determine the reporter's causality assessment. See Ref: PJP200200726.
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/08/02, concerning a female vaccinee who inadvertently received Fluvirin Subcutaneously on 11/07/02. No adverse reaction was reported in relation to the incident. There was insufficient information to determine the reporter's causality assessment. Cross reference with: PJP200200731, PJP200200741 and PJP200200749.
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/08/2002, concerning a male vaccinee who inadvertently received Fluvirin subcutaneously on 11/07/02. No adverse reaction was reported in relation to the incident. There was insufficient information to determine the reporter's causality assessment. Cross reference with: PJP200200731, PJP2002000743 and PJP200200728.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 08Nov02, concerning a male vaccinee who inadvertently received Fluvirin SC on 07Nov02. On 07Nov02 the vaccinee received 0.5ml Fluvirin SC. No adverse reaction was reported in relation to the incident. There was insufficient information to determine the reporter's causality assessment. Cross reference with: PJP-2002-00728, PJP200200690, PJP200200729, PJP200200793, PJP200200792, PJP200200791, PJP200200720, PJP200200745, PJP200200743.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 08Nov02, concerning a female vaccinee who inadvertently received Fluvirin SC on 07Nov02. On 07Nov02 the vaccinee received 0.5ml Fluvirin SC. No adverse reaction was reported in relation to the incident. There was insufficient information to determine the reporter's causality assessment. Cross reference with: PJP-2002-00731, PJP200200729, PJP200200749, PJP200200744, PJP200200742, PJP200200720, PJP200200745, PJP200200690, PJP200200743.
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 08Nov02, concerning a female vaccinee who inadvertently received Fluvirin SC on 07Nov02. On 07Nov02 the vaccinee received 0.5ml Fluvirin SC. No adverse reaction was reported in relation to the incident. There was insufficient information to determine the reporter's causality assessment. Cross reference with: PJP-2002-00731, PJP200200729, PJP200200749, PJP200200744, PJP200200741, PJP200200720, PJP200200745, PJP200200690, PJP200200743.
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 08Nov02, concerning a female vaccinee who inadvertently received Fluvirin SC on 07Nov02. On 07Nov02 the vaccinee received 0.5ml Fluvirin SC. No adverse reaction was reported in relation to the incident. There was insufficient information to determine the reporter's causality assessment. Cross reference with: PJP-2002-00731, PJP200200729, PJP200200799, PJP200200792, PJP200200791, PJP200200720, PJP200200745, PJP200200690.
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 08Nov02, concerning a female vaccinee who inadvertently received Fluvirin SC on 07Nov02. On 07Nov02 the vaccinee received 0.5ml Fluvirin SC. No adverse reaction was reported in relation to the incident. There was insufficient information to determine the reporter's causality assessment. Cross reference with: PJP-2002-00731, PJP200200729, PJP200200749, PJP200200742, PJP200200741, PJP200200720, PJP200200745, PJP200200690, PJP200200743.
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 08Nov02, concerning a female vaccinee who inadvertently received Fluvirin SC on 07Nov02. On 07Nov02 the vaccinee received 0.5ml Fluvirin SC. No adverse reaction was reported in relation to the incident. There was insufficient information to determine the reporter's causality assessment. Cross reference with: PJP200200731, PJP200200690, PJP200200728, PJP200200743, PJP200200729, PJP200200742, PJP200200741, PJP200200720.
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received from a healthcare professional on 08Nov02, concerning an 85 year old female vaccinee who received Fluvirin on 08Nov02, 15 days after receiving another influenza vaccine (brand unspecified) on 24Oct02. On 24Oct02 the vaccinee received one dose of influenza vaccine (brand unspecified) at a doctor's office outside of the nursing home. The vaccinee did not report this vaccination to the medical staff at the nursing home and on 08Nov02 the vaccinee inadvertently received Fluvirin at the nursing home. The vaccinee did not experience any adverse event. The reporter has assessed the relationship of the vaccine to the event as unclassifiable.
Age: 0.34
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Apnoea, Cardiac arrest, Circulatory collapse, Irritability, Oral intake reduced
Clinical narrative: Routine immunizations given at 3:42 PM on 11/18/04. Child went home and within 2 hours began to get fussy and did not take his bottle well. Mother put him to bed and around 8:00 PM the apnea alarm went off. CPR was unsuccessful and he was pronounced dead in the ER at 9:57 PM.  Autopsy report received and complete.
Age: 0.34
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Stupor
Clinical narrative: Routine immunizations given at 3:42 PM on 11/18/04. Child went home and within 2 hours began to get fussy and did not take his bottle well. Mother put him to bed and around 8:00 PM the apnea alarm went off. CPR was unsuccessful and he was pronounced dead in the ER at 9:57 PM.  Autopsy report received and complete.
Age: 62.0
Sex: F
Vaccine: FLU3
Symptoms: Feeling hot, Injection site erythema, Injection site swelling, Tachycardia
Clinical narrative: Left upper arm area size of 3 1/2 x 4 raised reddened warm area. Dr took pt home. Benadryl 25mg and 1 Tylenol at 11AM. 2pm felt tachycardia 117/71 p87 2:55pm 120/80 p 84.
Age: 30.0
Sex: F
Vaccine: FLUX
Symptoms: Feeling hot, Hypokinesia, Injection site oedema, Injection site pain
Clinical narrative: Where the shot was given the arm swole up the size of a baseball. I could not move it, it had fever in it. Could not move or touch the arm for 4 days. It was extremely painful.
Sex: F
Vaccine: DTAP, FLU3, IPV, MMR
Symptoms: Injection site erythema, Injection site mass, Tenderness
Clinical narrative: Erythema induration of right upper arm where shots given. Also tender to touch.
Age: 47.0
Sex: F
Vaccine: FLU3
Symptoms: Flushing, Hypersensitivity, Stomatitis, Unevaluable event
Clinical narrative: NONE Report received 02/21/2005: Mouth itchy, flushed skin, later had prolonged allergic reaction; symptoms persisted till 11/02/2004.  Treated wtih Benadryl, Tagamet.
Age: 50.0
Sex: U
Vaccine: FLU3
Symptoms: Dizziness, Flushing, Heart rate increased, Hyperhidrosis, Nausea
Clinical narrative: 10:10 flushed face, lighted headedness, nausea, perfuse perspiration, rapid pulse. Administered 0.3mg Epinephrine sq elevated feet.
Age: 42.0
Sex: F
Vaccine: FLU3, SMALL
Symptoms: Feeling hot, Injection site erythema, Injection site oedema, Tenderness
Clinical narrative: 40 y/o female s/p smallpox vaccine left outer deltoid area 01Feb05; c/o vaccine area redness, swelling and heat and tenderness x 5 days, area of redness measures 14cm-16cm by 11-13cm
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site mass
Clinical narrative: Pt had Dtap and IPV vaccine administered 2/15/05. Pt developed erythematous indurated rash (5x5.5cm) 2/16/05 and presented to clinic 2/17/05 AM.
Sex: F
Vaccine: MMR, PNC, VARCEL
Symptoms: Blister, Rash
Clinical narrative: Blister like rash all over
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Blister, Rash
Clinical narrative: Blister-like rash all over
Age: 1.6
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Viral infection
Clinical narrative: Child broke out in chicken pox several lesions over entire body.
Age: 18.0
Sex: M
Vaccine: HEP
Symptoms: Fatigue, Somnolence
Clinical narrative: Mother reported on 02/10/05 AM that pt had been sleeping since he returned home from college yesterday. She reports that pt refused to get up for dinner last night or for breakfast this AM. She denies fever, pain, n/v, confusion, resp distress or any other symptoms. She reports that this fatigue started after Hep vaccine yesterday and must be related to vaccine, she denies any adverse reaction following 1st HB vac 12/3/04.
Age: 40.0
Sex: F
Vaccine: UNK
Symptoms: Erythema, Rash macular
Clinical narrative: 40x30mm macular area of erythema
Age: 0.35
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Injection site erythema, Rash macular
Clinical narrative: Had red blotches on both legs. Was noticed in AM the next day 2/11/05. He was given Decodron.
Age: 41.0
Sex: F
Vaccine: TTOX
Symptoms: Feeling hot, Injection site mass, Injection site pain, Pruritus, Tenderness
Clinical narrative: Rec'd TD 2/10/05 at 12PM c/o small knot size of pea approx 24 hrs later. Pt states site grew larger and more painful. Pt c/o itching, soreness, and tenderness. Site measured today 80mm site hot and tender to touch.
Age: 18.0
Sex: F
Vaccine: MEN
Symptoms: Insomnia, Nightmare
Clinical narrative: Difficulty sleeping, nightmares
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Chills, Injection site erythema, Injection site oedema, Pyrexia
Clinical narrative: Left arm swelling/redness, fever, chills x 3 days
Age: 11.0
Sex: F
Vaccine: TD
Symptoms: Gaze palsy, Musculoskeletal stiffness, Screaming, Stomach discomfort
Clinical narrative: Pt awoke on 8/1/04 went into the bathroom, felt strange feeling in stomach, she yell, eyes rolled back and her body stiffened, lasted about 1 minute. She saw Dr on 11th of Aug and had a normal exam and she ordered an EEG.
Age: 12.0
Sex: M
Vaccine: HEP, VARCEL
Symptoms: Pruritus, Rash vesicular, Viral infection
Clinical narrative: Vesicular rash x 1 days on face, shoulders, right foot, forearms, forehead (probable varicella infection). Rx-Hydrocortisone cream 1% tid and Benadryl sinus 25/5ml q 6 prn, itching.
Age: 10.0
Sex: F
Vaccine: TD, VARCEL
Symptoms: Injection site pain, Tenderness
Clinical narrative: Sore arms no edema, no redness, tender to touch on left deltoid. Instructed mother to give Tylenol for the next 24 hours if soreness increases to contact MD. NBPH to contact individual next business day.
Age: 0.76
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Convulsion, Pyrexia
Clinical narrative: 2/14/05 at 12:15PM. Received phone call from mom stating with last set of immunizations child had high fever and had seizure. Took child to ER, fever was 103, no seizures after initial seizure at home. Child stayed in ER for a while then was sent home.
Age: 27.0
Sex: M
Vaccine: TTOX
Symptoms: Convulsion, Dizziness, Hyperhidrosis, Vomiting
Clinical narrative: Seizure started with lightheadedness then sweating about 4PM 2/4/05 then severe vomiting. Donor took Pepto Bismal but vomited again symptoms subsided about 12:30 AM Sat.
Age: 39.0
Sex: M
Vaccine: TTOX
Symptoms: Dizziness
Clinical narrative: After donation and Tetanus immunization, donor felt dizzy/faint feeling. Donor was pale. Donor lowered to bed. Water given. Donor recovered within ten minutes.
Sex: F
Vaccine: MMR
Symptoms: Infection
Clinical narrative: Chicken Pox
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Urticaria
Clinical narrative: Hives.
Age: 0.17
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Crying, Irritability, Screaming
Clinical narrative: Baby fussy after receiving DPTa, high pitched cry, more than 1 hour.
Age: 1.36
Sex: M
Vaccine: DTAPH
Symptoms: Coordination abnormal, Diarrhoea, Somnolence
Clinical narrative: Patient developed symptoms next day extreme drowsiness for 3 days problems with coordination loose stools. symptoms did resolve.
Age: 6.0
Sex: M
Vaccine: DTAPHEPBIP, MMR
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Rash vesicular
Clinical narrative: Erythema, induration and pain in right shoulder within hours of injection.  Within 24 hours vesicular rash on right shoulder extending to trunk.  Mild fever present.  Within 72 hours, rash extended to face and extremeties.  Treatment included acetaminophen and antihistamines.  Final outcome not yet known.
Age: 14.0
Sex: M
Vaccine: HEP, HEPA, TD, YF
Symptoms: Headache, Myalgia
Clinical narrative: Muscle aches and severe headache reported by parent 2 days post vaccination.  MD advised Motrin-to see MD if headache not resolved in 24 hours
Age: 0.18
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Agitation, Pyrexia, Somnolence, Urinary tract infection
Clinical narrative: 2-9-05 mother reported that infant developed fever aftershots given 1/12/05 for three days which peaked "third" day to 104. Infant was taken to ED then transferred to hospital.  Was in hospital 5 days with diagnosis of UTI.  Discharge Summary stated patient experienced UTI, fussiness and sleepiness.
Age: 4.0
Sex: M
Vaccine: RAB
Symptoms: Abdominal pain upper, Diarrhoea, Urticaria, Vomiting
Clinical narrative: PATIENT GIVEN RABIES VACCINE* AT APPROXIMATELY 1PM ON 2/6/05 IN THE OUTPATIENT DEPARTMENT.  HE STARTED WITH VOMITING AND DIARRHEA AROUND 12AM ON 2/7/05.  THE VOMITING WAS ON & OFF FOR 12-18 HOURS.  THE DIARRHEA LASTED FOR 3 DAYS.  ON 2/13/05, HE WOKE UP AND VOMITED ONCE DURING THE NIGHT.  HE HAS BEEN COMPLAINING OF STOMACH PAIN FOR 3-4 DAYS.  ON 2/16/05, HE STARTED WITH DIARRHEA AGAIN. ON 2/17/05, VOMITED ONCE AT ABOUT 4AM AND WHEN WOKE UP AROUND 7AM, WAS COVERED IN HIVES.  HE WAS SEEN ON 2/17/05 AND TOLD TO GIVE BENEDRYL.  *UNABLE TO FIND DOCUMENTATION OF VACCINE LOT #.  ACCORDING TO HOSPITAL PHARMACY WOULD PROBABLY BE THE SAME AS WHAT THEY STILL HAVE IN STOCK.  THE VACCINE IS RABAVERT LOT #336011.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema
Clinical narrative: Pneumovax PPV 23 administered 0815 2/16/05 in L upper arm subcutaneously.  RN noted red area 5 cm by 7 cm around vaccination site on 2/17/05.  No generalized signs/symptoms of reaction such as hives, itching, difficulty breathing, swelling. Vital Signs are stable.
Age: 4.0
Sex: M
Vaccine: MEN, TYP
Symptoms: Difficulty in walking, Pain
Clinical narrative: Within a few hours of administration of vaccine patient complaining of pain in right leg and cannot walk without pain.
Age: 44.0
Sex: F
Vaccine: HEPAB
Symptoms: Abdominal pain, Fatigue, Hypoaesthesia, Oedema peripheral, Paraesthesia
Clinical narrative: After about 15 minutes of having the shot administered in my left arm, my left hand starting tingling, then went numb.  I waited in the lobby for about 30-45 minutes to see if any more reaction was going to occur.  I left the medical facility to come back to work and my right hand also started going numb.  I called my husband to meet me for lunch to monitor any progress.  Both hands still being numb feeling, I started feeling my right leg starting to go numb after about 3 hours after taking the shot.  It subsided a little so I chose to drive home following my husband.  I was about .5 miles from home when felt a creepy, goose bump feeling going over the back of my head and my vision in my right eye got so blurry I could not see out of it.  I blinked numerous times to make sure it wasn't something in my contact lense and drove the remainder of the way home going.  My vision started to return by the time I made it home.  I was home about 30 minutes when my stomach had severe cramps for about 2-3 hours, then it subsided.  Then my left leg started going numb and I felt completely exhausted for 3 days and am still feeling "wiped out".  The numbness came and went all Friday night and into Saturday.  The numbness continued throughout the weekend off and on and into the next week and has forced me to rest. I am still experiencing numbness, swelling in my hands and feet, it is painful to type at a computer keyboard and the my energy level is very low.   My blood pressure was taken on Feb. 14, 2005 and it was somewhere around 170/90.  It has never been that high, but it was taken 40 minutes after a very light physical therapy session of which I couldn't do much because of my condition. I have made an appointment to have a complete physical done on Feb. 18, 2005, with my Internal Medicine doctor.  I talked to nurses at the Health Dept. and they all said they had never heard of a reaction like mine before.  Four days after the vaccination (Feb. 15, 2005), I received a flu shot with no adverse affects from that shot.